financetom
Business
financetom
/
Business
/
ONEOK Q3 Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ONEOK Q3 Earnings, Revenue Rise
Oct 28, 2025 1:52 PM

04:35 PM EDT, 10/28/2025 (MT Newswires) -- ONEOK ( OKE ) reported Q3 earnings late Tuesday of $1.49 per diluted share, up from $1.18 a year earlier.

Analysts polled by FactSet expected $1.44.

Revenue for the three months ended Sept. 30 was $8.63 billion, up from $5.02 billion a year earlier.

Analysts surveyed by FactSet expected $8.78 billion.

Shares of ONEOK ( OKE ) rose 1.3% during after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Uber, Five Below Collaborate to Launch Nationwide Delivery Through Uber Eats
Uber, Five Below Collaborate to Launch Nationwide Delivery Through Uber Eats
Jun 5, 2025
10:02 AM EDT, 06/05/2025 (MT Newswires) -- Uber Technologies ( UBER ) and Five Below ( FIVE ) said Thursday they've launched nationwide delivery of Five Below ( FIVE ) products through the Uber Eats app. Financial details of the partnership weren't disclosed. Shoppers can now order products from over 1,500 Five Below ( FIVE ) stores, and Uber One...
Canada And Europe Cut Back On Jack Daniel's As Trade War Dents Global Growth
Canada And Europe Cut Back On Jack Daniel's As Trade War Dents Global Growth
Jun 5, 2025
Brown-Forman Corp , the parent of Jack Daniel’s whiskey, Old Foster and other popular brands, saw its stock drop Thursday after it reported a weaker-than-expected fourth-quarter fiscal 2025. The spirits maker posted quarterly net sales of $894 million, down 7% from a year ago and 3% lower on an organic basis. The figure missed analyst expectations of $967.39 million. Diluted...
Estrella Immunopharma Adds Site for Phase 1/2 Trial in B-cell Non-Hodgkin's Lymphoma
Estrella Immunopharma Adds Site for Phase 1/2 Trial in B-cell Non-Hodgkin's Lymphoma
Jun 5, 2025
09:54 AM EDT, 06/05/2025 (MT Newswires) -- Estrella Immunopharma ( ESLA ) said Thursday it activated a second site for its phase 1/2 trial assessing EB103 autologous T-cell therapy in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The new site at Baylor Scott and White Research Institute in Dallas, Texas, is now open for enrollment, the company said. The...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved